Evidence map›Paper›PMID 40537517›Full record

ReviewSkeletal radiology2025

Recognising serous atrophy of bone marrow: a review of imaging findings.

Tania Toma, Stuart Viegas, Dimitri Amiras, Christopher Lord

Abstract readReview
In one paragraph

Review in Skeletal radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Tania TomaDepartment of Radiology, Imperial College NHS Healthcare Trust, Praed Street, London, W2 1NY, UK.
Stuart ViegasDepartment of Neurology, Imperial College NHS Healthcare Trust, Praed Street, London, W2 1NY, UK.
Dimitri AmirasDepartment of Radiology, Imperial College NHS Healthcare Trust, Praed Street, London, W2 1NY, UK. d.amiras@imperial.ac.uk.
Christopher LordDepartment of Radiology, Imperial College NHS Healthcare Trust, Praed Street, London, W2 1NY, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Serous atrophy of bone marrow (SABM) is a rare bone marrow disorder associated with severe illness and poor nutritional state. This results in characteristic MRI signal alterations of the bone marrow and surrounding soft tissues. The unusual imaging features are often misinterpreted as technical error or erroneously attributed to underlying malignancy, resulting in unnecessary additional imaging. Therefore, it is important to differentiate SABM from technical failures and other infiltrating marrow processes. This review provides an overview of the imaging characteristics of SABM and associated imaging pitfalls, based on examples from our own practice.

Indexed as

Bone MarrowBone Marrow DiseasesMagnetic Resonance ImagingAtrophyDiagnosis, DifferentialHumansBone marrowDifferential diagnosisMRISerous atrophy

Identifiers

PMID40537517
PMCPMC12552353

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.